Process development is the foundation for the successful commercialization of cell and gene therapies. The complexities of CGT manufacturing necessitate a step-by-step approach to developing robust, reproducible, and commercially viable processes in a phase-appropriate and streamlined manner. Harnessing scalable cGMP manufacturing platform technologies whilst maintaining flexibility in process development is a critical focus for the CGT manufacturing field as a whole.

This collection of curated content from Lonza explores the key role of process development in establishing a clear path to successful commercial cGMP manufacture of advanced therapies.